32636651|t|circPDSS1 Stimulates the Development of Colorectal Cancer via Activating the Wnt/beta-Catenin Signaling.
32636651|a|OBJECTIVE: This study aims to illustrate the role of circPDSS1 and the Wnt/beta-catenin signaling in the development of colorectal cancer (CRC). PATIENTS AND METHODS: Cancerous mucosa and normal paracancerous mucosa tissues more than 5 cm away from the tumor were surgically collected from 56 CRC patients. circPDSS1 levels in collected tissues and CRC cell lines were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The influence of circPDSS1 on clinical features of CRC patients was analyzed. After knockdown of circPDSS1 in HCT-8 and HCT-116 cells, phenotype changes were examined by Transwell, tube formation and wound healing assay. Western blot and rescue experiments were finally performed to uncover the role of circPDSS1 and the Wnt/beta-catenin signaling in the development of CRC. RESULTS: circPDSS1 was upregulated in CRC mucosa tissues than controls. High level of circPDSS1 predicted high rates of lymphatic metastasis and distant metastasis, and poor prognosis in CRC patients. Knockdown of circPDSS1 attenuated migratory ability and angiogenesis in CRC cells. Protein levels of key genes in the Wnt/beta-catenin signaling, including beta-catenin, GSK-3beta, c-Myc, MMP-9 and cyclin D1 were downregulated in CRC cells transfected with sh-circPDSS1. Overexpression of beta-catenin reversed the role of circPDSS1 in attenuating migratory ability and angiogenesis in CRC cells. CONCLUSION: Upregulated circPDSS1 in CRC is closely linked to lymphatic metastasis, distant metastasis and overall survival. It stimulates the migratory ability and angiogenesis in CRC cells via activating the Wnt/beta-catenin signaling.
32636651	40	57	Colorectal Cancer	Disease	MESH:D015179
32636651	81	93	beta-Catenin	Gene	1499
32636651	180	192	beta-catenin	Gene	1499
32636651	225	242	colorectal cancer	Disease	MESH:D015179
32636651	244	247	CRC	Disease	MESH:D015179
32636651	250	258	PATIENTS	Species	9606
32636651	358	363	tumor	Disease	MESH:D009369
32636651	398	401	CRC	Disease	MESH:D015179
32636651	402	410	patients	Species	9606
32636651	454	457	CRC	Disease	MESH:D015179
32636651	597	600	CRC	Disease	MESH:D015179
32636651	601	609	patients	Species	9606
32636651	656	661	HCT-8	CellLine	CVCL:2478
32636651	666	673	HCT-116	CellLine	CVCL:0291
32636651	871	883	beta-catenin	Gene	1499
32636651	916	919	CRC	Disease	MESH:D015179
32636651	959	962	CRC	Disease	MESH:D015179
32636651	1041	1061	lymphatic metastasis	Disease	MESH:D008207
32636651	1066	1084	distant metastasis	Disease	MESH:D009362
32636651	1108	1111	CRC	Disease	MESH:D015179
32636651	1112	1120	patients	Species	9606
32636651	1194	1197	CRC	Disease	MESH:D015179
32636651	1244	1256	beta-catenin	Gene	1499
32636651	1278	1290	beta-catenin	Gene	1499
32636651	1292	1301	GSK-3beta	Gene	2932
32636651	1303	1308	c-Myc	Gene	4609
32636651	1310	1315	MMP-9	Gene	4318
32636651	1320	1329	cyclin D1	Gene	595
32636651	1352	1355	CRC	Disease	MESH:D015179
32636651	1411	1423	beta-catenin	Gene	1499
32636651	1508	1511	CRC	Disease	MESH:D015179
32636651	1556	1559	CRC	Disease	MESH:D015179
32636651	1581	1601	lymphatic metastasis	Disease	MESH:D008207
32636651	1603	1621	distant metastasis	Disease	MESH:D009362
32636651	1700	1703	CRC	Disease	MESH:D015179
32636651	1733	1745	beta-catenin	Gene	1499
32636651	Association	MESH:D015179	4609
32636651	Association	MESH:D015179	2932
32636651	Association	MESH:D015179	4318
32636651	Association	MESH:D015179	1499
32636651	Association	MESH:D015179	595

